Skip to content

Navigation contrast-enhanced ultrasound evaluation of liver cancer ablation border security research

Navigation contrast-enhanced ultrasound evaluation of liver cancer ablation border security research

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DCD-15006093
Enrollment
Unknown
Registered
2015-01-23
Start date
2011-02-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma

Interventions

Gold Standard:
Index test:

Sponsors

Department of Ultrasound, the Third Affilicated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
32 Years to 68 Years

Inclusion criteria

Inclusion criteria: (1) has been diagnosed with liver cancer patients; (2) focal lesions biggest diameter <5 cm, and number <3, feasible radiofrequency ablation treatment; (3) the patient's general condition and liver function good, can tolerate under general anesthesia radiofrequency treatment of liver cancer; (4) ethics committee approval, the participants signed informed consent.

Exclusion criteria

Exclusion criteria: (1) Ablation in patients with should be used as artificial auxiliary methods, such as ascites or artificial hydrothorax, avoid caused by artificial ascites or pleural effusion disappeared after abdominal ultrasound can't display and evaluation of lesions; (2) patients should be gall bladder resection or lobe resection, and at the same time avoid the shape changes in liver can't accurate image registration.

Design outcomes

Primary

MeasureTime frame
Navigation ultrasound imaging performance after ablation;

Countries

China

Contacts

Public ContactHuang DongMei
Hdm3030@126.com+86 020 85252010

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026